Iloperidone

Overview

Iloperidone is an atypical antipsychotic used for the treatment of schizophrenia. It operates as an antagonist for certain dopamine and serotonin receptors, helping manage symptoms of the disorder.

API suppliers (5)

Suppliers of Iloperidone backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• SYMED LABS LTDIndia1 active DMF
• MYLAN LABORATORIES LTD

Patent & exclusivity (US)

Per the FDA Orange Book (102 approved US products), the latest listed US patent on Iloperidone expires 27 Sept 2035 and exclusivity 23 Sept 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide

Canonical SMILES

CCN(CC)CC(=O)NC1=C(C=CC=C1C)C

InChIKey

NNJVILVZKWQKPM-UHFFFAOYSA-N

Therapeutic areas